Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin for Prevention of Vascular Graft Disease in Renal Transplant
NCT00565474Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2001
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluvastatin in Vascular Graft Disease, sponsored by Novartis. Started Sep 2001; status: completed.
02
Drugs
fluvastatin
03
Conditions
Vascular Graft Disease
Beyond the preview
Go deeper on NCT00565474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565474.